Conductive keratoplasty for presbyopia: 1-Year results

Journal of Refractive Surgery

Volumn 22, Issue 2, 2006, Pages 137-144

  Stahl, Jason E ^a  

^a Durrie Vision   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC TROMETAMOL; OFLOXACIN; PREDNISOLONE ACETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; KERATOPLASTY; MALE; POSTOPERATIVE CARE; PRESBYOPIA; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33644501108     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081-597x-20060201-10     Document Type: Article

References (5)

1. United States FDA PMA P010018: Refractec ViewPoint CK System. Physician's Reference Guide for Treatment of Presbyopic Emmetropes and Hyperopes to Improve Near Vision Utilizing Conductive Keratoplasty (CK). Irvine, Calif: Refractec Inc; 2004.
2. US Census Bureau. Selected Social Characteristics of Baby Boomers 26 to 44 years old: 1990. Available at: www.census.gov/population/censusdata/cph-1- 160.txt. Accessed March 2004.
3. Pallikaris IG, Naoumidi TL, Panagopoulou SI, Alegakis AK, Asyrakakis NI. Conductive keratoplasty for low to moderate hyperopia: 1-year results. J Refract Surg. 2003;19:496-506.
4. McDonald MB, Durrie D, Asbell P, Maloney R, Nichamin L. Treatment of presbyopia with conductive keratoplasty: six-month results of the 1-year United States FDA clinical trial. Cornea. 2004;23:661-668.
5. Durrie DS. CK Centration Study. Presented at: Refractec Users Meeting; April 13, 2002; Carefree, Ariz.